TISSUE DISTRIBUTION AFTER A SINGLE SUBCUTANEOUS ADMINISTRATION OF 2,3,7,8-TETRABROMODIBENZO-P-DIOXIN IN COMPARISON WITH TOXICOKINETICS OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN IN FEMALE WISTAR RATS
T. Nagao et al., TISSUE DISTRIBUTION AFTER A SINGLE SUBCUTANEOUS ADMINISTRATION OF 2,3,7,8-TETRABROMODIBENZO-P-DIOXIN IN COMPARISON WITH TOXICOKINETICS OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN IN FEMALE WISTAR RATS, Life sciences, 58(4), 1995, pp. 325-336
Citations number
17
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Tissue concentrations of 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) and
induction of ethoxyresorufin O-deethylase (EROD) were determined in f
emale Wistar rats following a single subcutaneous (s.c.) injection of
TBDD. Two sets of experiments were performed in order to study (a) the
time course after a single s.c. administration of 600 ng TBDD/kg body
wt up to 78 days, and (b) the dose-response seven days after a single
s.c. injection of different doses of TBDD (3 to 3,000 ng/kg body wt).
The results obtained on toxicokinetics and enzyme induction were comp
ared with those following a single s.c. administration of 300 ng/kg bo
dy wt 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Three days after the
injection, approximately 93% of TBDD and 90% of TCDD had been absorbe
d. Fourteen days after s.c. injection less than 1% of the administered
dose of both substances remained at the injection site. Three days af
ter a single s.c. injection of 600 ng TBDD/kg body wt and 300 ng TCDD/
kg body wt, the maximum tissue concentrations in the liver amounted to
(M +/- S.D.) 5.7 +/- 0.8 and 4.7 +/- 0.9 ng/g wet weight, respectivel
y. In adipose tissue, the peak concentration was 3.2 +/- 0.2 ng/g wet
weight for TBDD on day 14, and 0.8 +/- 0.1 ng/g for TCDD on day 7. Thr
oughout the study, the concentration ratio in the TCDD-treated group w
as always at least twice as high as that in the TBDD-treated group. Th
e elimination half-life (t(1/2)) of TBDD and of TCDD in the liver was
13.3 and 13.6 days, respectively. In the adipose tissue the t(1/2) of
TCDD was 24.5 days but no reliable t(1/2) could be calculated for TBDD
(t(1/2) = 39.4 days with a 95% confidence interval of 25.9 to 82.4 da
ys). Tissue content of TBDD and TCDD in liver and adipose tissue incre
ased dose-dependently, and the linear regression in a double-logarithm
ic plot showed a straight line. Time course of the induction of hepati
c EROD activity after treatment with 600 ng TBDD/kg body wt was almost
identical with that observed following a single dose of 300 ng TCDD/k
g body wt. The induction of hepatic EROD activity was linearly correla
ted in a double-logarithmic plot to the hepatic concentrations of the
congeners (both TBDD and TCDD). The slopes of the dose-response curves
after administration of TBDD and TCDD were almost parallel for tissue
concentrations ranging from 0.1 to 30 ng/g wet weight.